Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

27.72
Delayed Data
As of Sep 23
 +0.87 / +3.24%
Today’s Change
18.55
Today|||52-Week Range
225.54
-72.73%
Year-to-Date

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 35.50, with a high estimate of 81.00 and a low estimate of 16.00. The median estimate represents a +28.07% increase from the last price of 27.72.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in Valeant Pharmaceuticals. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.79
Sales
$2.5B
Reporting Date
Oct 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 28.18%
 
 
 
 
 
 
Growthannually -35.55%
 
 
 
 
 
 

Sales

Growthquarterly 5.26%
 
 
 
 
 
 
Growthannually -4.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.